Prevention of traveler's diarrhea by the tablet form of bismuth subsalicylate.

In a randomized double-blind study, Swiss adults traveling to tropical countries for 12 to 28 days took a solid formulation of bismuth subsalicylate (1.05 or 2.1 g/day on a twice-daily regimen) or placebo. Efficacy was evaluated in 231 volunteers. Diarrheal incidence was reduced by 41% in persons ta...

Descripción completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Autores principales:	Steffen, R, DuPont, H L, Heusser, R, Helminger, A, Witassek, F, Manhart, M D, Schär, M
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	American Society for Microbiology (ASM) 1986
Materias:	Research Article
Acceso en línea:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180455/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3518624/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.29.4.625
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!